Navigating AI Adoption in Healthcare: Insights From HonorHealth's CMIO

Why It Matters

Speeding AI deployment is now a strategic imperative; organizations that lag risk losing efficiency gains and market share. HonorHealth’s balanced vendor approach offers a roadmap for other health systems navigating similar challenges.

Key Takeaways

• 94% say AI delays cause competitive disadvantage
• 40% ready to deploy third‑party AI now
• HonorHealth uses single Epic instance, simplifying vendor management
• ROI measured by patient outcomes and cost savings
• Smaller systems may leverage agility as AI equalizer

Pulse Analysis

The healthcare sector is at a tipping point where artificial intelligence moves from experimental to essential. Recent Qventus research shows that 94% of CIOs and CMIOs believe a one‑ to two‑year lag in AI operationalization will erode competitive advantage, underscoring the urgency for rapid adoption. For integrated networks like HonorHealth, the challenge lies in aligning AI initiatives with existing electronic health record (EHR) infrastructures, primarily Epic, while remaining open to best‑of‑breed third‑party solutions that address specific workflow gaps.

Vendor management emerges as a critical differentiator. HonorHealth’s strategy of maintaining a single Epic instance reduces the complexity of integrating multiple AI tools, yet the organization still collaborates with external vendors for niche capabilities such as ambient analytics. This hybrid approach mirrors broader industry trends: 40% of health leaders are prepared to deploy proven third‑party AI now, while reliance on EHR‑driven roadmaps is waning. Effective oversight—treating AI vendors like any other technology partner—helps mitigate risks associated with fragmented implementations and ensures consistent data governance across the network.

Measuring return on investment remains the linchpin for sustainable AI scaling. Anderson emphasizes a dual focus on hard metrics like cost avoidance and revenue capture, alongside soft outcomes such as clinician satisfaction and patient experience. Without demonstrable ROI, even the most promising AI tools become non‑starters. As AI matures, leadership roles may recede, positioning the technology as a ubiquitous tool rather than a siloed function, a shift that could level the playing field for smaller, more agile health systems.